GSS genetic signatures limited

Ann: Quarterly Activities/Appendix 4C Cash Flow Report, page-5

  1. 387 Posts.
    lightbulb Created with Sketch. 67
    Staff and Admin costs over $6m for the Qtr.
    Sales (excl R&D money received) $3.2m

    No customers that have signed for the new approved FDA entoeriic testing kits. "Hopeful that customers will sign up"


    The new CEO needs to really show some leadership here-
    - restructure of staff and admin costs going forward. This isn't sustainable running wages and admin @200% of sales.
    - get these Hospitals to sign and and use these as test cases moving forward (even it means supplying product at cost for 6-12 months)
    - create a pipeline of future roll outs....

    Not sure about this company - give them 6 months to start showing results!


 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)
Last
36.5¢
Change
-0.010(2.67%)
Mkt cap ! $82.90M
Open High Low Value Volume
36.5¢ 36.5¢ 36.5¢ $160 438

Buyers (Bids)

No. Vol. Price($)
3 19601 36.5¢
 

Sellers (Offers)

Price($) Vol. No.
37.5¢ 32411 1
View Market Depth
Last trade - 13.38pm 04/07/2025 (20 minute delay) ?
GSS (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.